Results from HIVEC-II for Intermediate-risk Non–muscle-invasive Bladder Cancer: Is This a Dead End for Mitomycin C Hyperthermia?
- 1 June 2023
- journal article
- editorial
- Published by Elsevier BV in European Urology
- Vol. 83 (6), 505-507
- https://doi.org/10.1016/j.eururo.2023.03.004
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non–muscle-invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Controlled TrialEuropean Urology, 2023
- Combination of hyperthermia and intravesical chemotherapy for the treatment of pT1 stage bladder cancer: A retrospectively clinical studyAsia-Pacific Journal of Clinical Oncology, 2023
- Intermediate-risk Non–muscle-invasive Bladder Cancer: Updated Consensus Definition and Management Recommendations from the International Bladder Cancer GroupEuropean Urology Oncology, 2022
- Long-term efficacy of hyperthermic intravesical chemotherapy for BCG-unresponsive non-muscle invasive bladder cancerUrologic Oncology: Seminars and Original Investigations, 2022
- Recirculating hyperthermic intravesical chemotherapy with mitomycin C (HIVEC) versus BCG in high-risk non-muscle-invasive bladder cancer: results of the HIVEC-HR randomized clinical trialWorld Journal of Urology, 2022
- Intravesical Chemohyperthermia vs. Bacillus Calmette-Guerin Instillation for Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer: A Systematic Review and Meta-AnalysisFrontiers in Surgery, 2021
- Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non–Muscle-invasive Bladder CancerEuropean Urology, 2016
- Chemohyperthermia in non-muscle-invasive bladder cancer: An overview of the literature and recommendationsInternational Journal of Hyperthermia, 2016
- Recirculant hyperthermic IntraVEsical chemotherapy (HIVEC) in intermediate–high-risk non-muscle-invasive bladder cancerInternational Journal of Hyperthermia, 2016